Our aim is to use scientific discoveries to improve human health. To that end we are developing new methods to better prevent diseases and to more precisely and effectively treat them. This booklet lists, in alphabetical order, what we need to achieve these goals. From A to Z, it provides a good first overview of the BIH.
On June 24, 2021, the BIH Governing Board confirmed Dr. Michael Frieser as the new Administrative Director of the Berlin Institute of Health at Charité (BIH). He succeeds Andrea Runow, who has held the post since January 1, 2019, and is now retiring. Dr. Michael Frieser, 55, who currently heads the Administration Division at the…
During the Corona pandemic, half a million researchers from more than 170 different fields published articles about the virus or the COVID-19 disease. Many of them were not really virus-experts, even automobile researchers published about Corona. In the new episode of the BIH-podcast, John Ioannidis, famous meta-researcher from Stanford and Berlin,…
Prof. Dr. Christopher Baum has taken over the position of Chief Translational Research Officer at Charité as of January 1. The position was created in the course of the integration of the Berlin Institute of Health (BIH). The molecular physician is thus responsible for the new third pillar "Translational Research Unit" of Charité –…
Clinician Scientists, their mentors and clinic directors discussed research projects and strategic BIH issues at Schloss Genshagen on 23/24 January 2020. Another highlight was the fireside chat between BIA Director Prof. Dragun and the new Chairman of the Charité Board Prof. Heyo Kroemer.
